Exclusive: How are import/export restrictions both within and outside the European Union affecting the food supplements industry supply chain? HBW Insight speaks to Food Supplements Europe and the International Alliance of Dietary/Food Supplements Associations to find out. 

Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.

Feature: Should consumers be turning to food supplements to support their immune systems during the COVID-19 epidemic? HBW Insight speaks to Professor David Richardson, scientific adviser to the Council for Responsible Nutrition UK and Nick Bennett, head of Nutrition at IVC Brunel Healthcare Ltd.  

As the coronavirus continues to spread across Europe, HBW Insight editors Tom Gallen and David Ridley discuss how the pandemic is impacting the region's consumer healthcare market. 

Dietary Supplements Regulatory Summit scheduled for 27 May in Washington is postponed. Even as supplies from China are slowed or interrupted due to Covid-19, though, sales of some consumer health products jump as consumers respond to the public health threat.

UNPA anticipates supplies of a ‘significant number’ of China-sourced supplement ingredients will be ‘critical’ by late April as Covid-19 disrupts shipments. During a recent webinar, UNPA CEO Loren Israelsen said he expects disruptions to continue until at least mid-year.